EFFICIENT AND SENSITIVE ANALYSIS OF BIOMOLECULAR INTERACTIONS BETWEEN PALBOCICLIB AND HUMAN SERUM ALBUMIN USING FLUORESCENCE QUENCHING MECHANISM
Abstract
Keywords
References
- 1. Khan, M.I., Nadeem, I., Majid, A., et al. (2021). Adsorption mechanism of Palbociclib anticancer drug on two different functionalized nanotubes as a drug delivery vehicle: A first principle’s study. Applied Surface Science, 546, 149129. [CrossRef]
- 2. Wang, Y., Wang, F., Shen, Y., et al. (2018). Tumor-specific disintegratable nanohybrids containing ultrasmall inorganic nanoparticles: From design and improved properties to cancer applications. Materials Horizons, 5(2), 184-205. [CrossRef]
- 3. Chu, C., Lyu, X., Wang, Z., et al. (2020). Cocktail polyprodrug nanoparticles concurrently release cisplatin and peroxynitrite-generating nitric oxide in cisplatin-resistant cancers. Chemical Engineering Journal, 402, 126125. [CrossRef]
- 4. Inglot, T.W. (2025). Exploring pitolisant binding to human serum albumin: Insights from multi-spectroscopic, molecular docking and molecular dynamics studies. Journal of Molecular Structure, 1341, 142698. [CrossRef]
- 5. Zsila, F. (2013). Subdomain IB is the third major drug binding region of human serum albumin: Toward the three-sites model. Molecular Pharmaceutics, 10(5), 1668-1682. [CrossRef]
- 6. Colmenarejo, G. (2003). In silico prediction of drug-binding strengths to human serum albumin. In Medicinal Research Reviews. 23 (3), 275-301. [CrossRef]
- 7. Ghuman, J., Zunszain, P.A., Petitpas, I., et al. (2005). Structural basis of the drug-binding specificity of human serum albumin. Journal of Molecular Biology, 353(1), 38-52. [CrossRef]
- 8. Calucică, D.M., Manda, C.V., Găman, A.M., et al. (2022). Development of a SPE-LC-MS method for the Quantitation of palbociclib and abemaciclib in human plasma. Molecules, 27(23), 8604. [CrossRef]
Details
Primary Language
English
Subjects
Pharmaceutical Analytical Chemistry
Journal Section
Research Article
Authors
Ahmet Cetinkaya
*
0000-0001-5014-0907
Türkiye
Merve Yence
0000-0003-4197-1009
Türkiye
Esen Bellur Atici
0000-0002-4093-441X
Türkiye
Sibel A. Özkan
0000-0001-7494-3077
Türkiye
Early Pub Date
January 14, 2026
Publication Date
January 14, 2026
Submission Date
August 12, 2025
Acceptance Date
September 25, 2025
Published in Issue
Year 2026 Volume: 50 Number: 1